ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

FDA: Silicone Breast Implants Safe, But Not “Lifetime Device”

June 24, 2011

NCI To Study Whether It Gets The Most From Advisors.

March 8, 2002

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

DCT Will Consider Planning, Center Core Supplemental, Program Project Grants In $5 Million Surgical Oncology Development Effort

October 10, 1980

Also in this 8-page issue: Vitamin E doesn’t prevent heart events, cancer, Women’s Health Study finds.

July 8, 2005